Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr;12(4):1552–1560. doi: 10.21037/jtd-20-1555

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2020 Journal of Thoracic Disease. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Effects of 80 mg/kg wogonoside in vivo. (A) Tumors at day 30 in both groups and changes in tumor volume during treatment. (B) Immunohistochemical staining of VEGF and vimentin, and immunohistochemical positive cells were counted for (C) VEGF and (D) vimentin. (E) CD34 content in PBMC tested with FACS after treatment. *, P<0.05 compared with the control group.